DoD Kidney Cancer, Translational Research Partnership Award
ID: 355339Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355339
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Kidney Cancer Translational Research Partnership Award to support innovative partnerships between clinicians and research scientists aimed at advancing kidney cancer research and improving patient care. This grant opportunity encourages collaborative efforts to address significant challenges in kidney cancer, with a focus on translating research findings into clinical applications that benefit active-duty military members, veterans, and the general public. The total estimated funding for this initiative is approximately $7.68 million, with individual awards capped at $800,000 over a three-year period. Key deadlines include a pre-application letter submission by September 24, 2024, and a full application due by October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524KCRPTRPA_GG.pdf
    HT942524KCRPTRPA_GG2.pdf
    The Department of Defense (DoD) seeks to award grants for kidney cancer research through its FY24 Kidney Cancer Research Program (KCRP). This initiative aims to foster translational research collaborations between researchers and clinicians to accelerate advancements in kidney cancer understanding and patient care. The focus is on projects that enhance the movement of innovative ideas into clinical applications, improving outcomes for patients. Applicants must address at least one of the specified FY24 KCRP Focus Areas, emphasizing basic biology research, screening strategies, novel treatments, quality-of-life improvements, and health disparity mitigation. The research should align with the program's overarching strategic goals. This two-step application process requires a Letter of Intent followed by a full application. Full applications must include a detailed project narrative, technical abstracts, lay abstracts, statements of work, and impact statements. The budget is limited to a maximum combined direct cost of $800,000 for a three-year period. The application's peer review evaluates research strategy, partnership potential, translational aspects, and impact, while programmatic review considers overall relevance to the KCRP objectives. Critical dates include the Letter of Intent submission deadline on September 24, 2024, and the full application deadline on October 15, 2024. The DoD aims to fund approximately six applications, with each selected project receiving up to $800,000 in combined direct costs. Applicants must be affiliated with eligible organizations, with at least one partner having expertise in kidney cancer research or patient care. This opportunity seeks to foster cutting-edge research collaborations, ultimately contributing to improved kidney cancer management and care for military personnel, veterans, and the wider population.
    HT942524KCRPTRPA_GG3.pdf
    The Department of Defense (DOD) is announcing the FY24 Kidney Cancer Translational Research Partnership Award to enhance research and clinical care for kidney cancer, particularly benefiting active-duty military members and veterans. With an appropriation of $50 million, this funding opportunity promotes innovative, high-impact research focused on understanding kidney cancer biology, developing novel therapeutic strategies, improving patient care, and addressing health disparities. Applicants must form partnerships between clinicians and research scientists, demonstrating collaborative efforts aimed at overcoming significant kidney cancer challenges. The application process is streamlined into two steps: a pre-application via the Electronic Biomedical Research Application Portal (eBRAP) and a full application through Grants.gov. Key deadlines include a pre-application letter submission by September 24, 2024, and a full application due by October 15, 2024. The maximum award budget is $800,000 over three years, and funding will be allocated based on scientific merit as assessed through peer and programmatic reviews. This initiative is crucial for fostering multi-disciplinary collaborations and advancing kidney cancer research, ultimately aiming to improve outcomes for patients affected by this disease.
    Similar Opportunities
    DoD Kidney Cancer, Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a funding opportunity for the Fiscal Year 2024 Kidney Cancer Research Program (KCRP) Clinical Trial Award, aimed at supporting innovative clinical trials that can significantly impact kidney cancer treatment and management. The program encourages proposals that range from preliminary proof-of-concept trials to large-scale studies, emphasizing the need for robust preliminary data, access to suitable patient populations, and necessary materials for the trials. With an estimated total program funding of $6.4 million and the expectation of awarding approximately two grants, interested applicants must submit a pre-application letter of intent by September 24, 2024, and a complete application by October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Kidney Cancer, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Fiscal Year 2024 Kidney Cancer Research Program's Idea Development Award, aimed at advancing innovative and high-impact kidney cancer research. This grant opportunity encourages projects that align with strategic goals such as enhancing understanding of kidney cancer biology, developing novel therapies, and addressing healthcare disparities, with a focus on benefiting active-duty military personnel, veterans, and the general public. The total estimated funding for this program is approximately $18.56 million, with around 13 awards anticipated, and key deadlines include a pre-application due by September 24, 2024, and a full application deadline of October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Kidney Cancer, Academy of Kidney Cancer Investigators - Early-Career Scholar Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Academy of Kidney Cancer Investigators - Early-Career Scholar Award, aimed at fostering innovative kidney cancer research by supporting early-career scholars. This program encourages applicants to develop research projects that address critical areas in kidney cancer biology, novel therapies, and healthcare disparities, while providing intensive mentoring and networking opportunities within a collaborative Academy environment. With an estimated total program funding of $2.32 million, the initiative anticipates awarding approximately two grants, with applications due by October 15, 2024, following a pre-application letter of intent due by September 24, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Kidney Cancer, Academy of Kidney Cancer Investigators – Leadership Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is inviting applications for the FY24 Kidney Cancer Academy of Kidney Cancer Investigators – Leadership Award under the Kidney Cancer Research Program (KCRP). This funding opportunity aims to support established kidney cancer researchers at the associate professor level or higher, focusing on enhancing research capacity, fostering collaboration, and mentoring early-career investigators in kidney cancer research. With an estimated total program funding of $2.4 million, the initiative seeks to award two cooperative agreements, with applications due by September 19, 2024, following a pre-application deadline of August 29, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Peer Reviewed Cancer, Impact Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Peer Reviewed Cancer Impact Award, aimed at funding high-impact cancer research that benefits Service Members, Veterans, and their families. This grant opportunity seeks to support mature research projects that address critical cancer issues, with a focus on translational or clinical research that demonstrates the potential for significant near-term impact on patient outcomes. With an estimated total program funding of $16 million and the expectation of awarding approximately 10 grants, applicants must submit a pre-application by June 21, 2024, followed by a full application due by September 26, 2024. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity titled "DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award" for Fiscal Year 2024. This funding initiative aims to support the rapid implementation of clinical trials that have the potential to significantly impact cancer treatment and management, particularly for military personnel and their families, addressing specific topic areas related to military health. With an estimated total program funding of $24 million and the expectation of awarding up to five grants, eligible applicants can submit proposals that demonstrate the feasibility and relevance of their clinical trials, with a maximum award amount of $3 million. Interested parties must submit their applications by October 15, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DOD Pancreatic Cancer, Translational Research Partnership Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Pancreatic Cancer Translational Research Partnership Award, aimed at fostering innovative collaborations between clinician investigators and research scientists to advance pancreatic cancer research. This grant supports projects that require equal contributions from both partners, focusing on critical areas such as early detection, supportive care interventions, and drug resistance mechanisms, with an emphasis on translating scientific discoveries into clinical applications. The total funding available for this opportunity is $4.8 million, with individual proposals eligible for up to $750,000, and the application process involves a two-step submission via eBRAP and Grants.gov, with a closing date of October 3, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Cancer, Idea Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Peer Reviewed Cancer Idea Award, a federal grant aimed at supporting innovative and high-risk cancer research relevant to military personnel, Veterans, and their families. This grant encourages proposals that challenge existing paradigms and explore new perspectives in cancer research, specifically excluding incremental advancements or ongoing projects. With an estimated total program funding of $16 million and the expectation of awarding approximately 20 grants, each project can receive up to $400,000 over a two-year period. Interested applicants must submit a pre-application by June 21, 2024, with full applications due later for those invited to proceed, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Rare Cancers, Resource Community Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research Acquisition Activity, is offering the FY24 Rare Cancers Resource and Community Development Award to support research initiatives aimed at improving outcomes for individuals with rare cancers. This grant opportunity seeks to develop clinical or preclinical datasets and research resources that address significant gaps in rare cancer research, emphasizing collaboration among researchers, patients, and clinicians, with a mandatory inclusion of patient advocates in the project planning and implementation phases. With an estimated total funding of $6.4 million available for up to five awards, each project can receive a maximum of $800,000 over a four-year period. Interested applicants must submit a pre-application followed by a full application, with the submission deadline set for September 23, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Rare Cancers, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the Fiscal Year 2024 Rare Cancers Idea Development Award to support innovative research aimed at advancing the understanding and treatment of rare cancers. This grant opportunity encourages proposals that focus on understanding molecular pathways, developing tumor-specific models, or identifying novel therapies, with an emphasis on research that can significantly impact patient outcomes. The total funding available for this program is approximately $17.5 million, with individual awards capped at $350,000 over a three-year period, and applications are due in two stages: a pre-application by June 17, 2024, and a full application by September 23, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.